Frequently Asked Questions

Robert... You seem to pay a lot of attention to emerging technologies. With the boom and bust history of tech stocks... isn't this something to stay away from?

Absolutely not! By the late nineties, any analyst worth their salt knew that a great shakeup was coming, and took steps to protect their clients. The problem was that too many investors jumped into the market blindly, without looking at the real substance behind many of these offerings.

Some of these doomed companies had concepts that will someday rock the world... but no hope for profit anytime soon. Others were bad ideas to start with... like trying to sell perishable groceries over the Internet. Still others made a big splash spending millions on Super Bowl ads... but had overestimated their market... had inadequate support structures in place... or suffered from poor management.

Meanwhile, many other tech issues have continued to grow, split, and grow again, making great fortunes for their investors. The secret is knowing what to buy... when to buy... and when to sell!

In fact, the NASDAQ has always outperformed the rest of the market by a huge margin. And, the opportunity to win big with high-tech Growth Stocks is now greater than ever before in our history!

Robert... Are all the stocks you recommend newer issues and start-ups?

Hardly. Despite the allure these offer of amassing extraordinary profits quickly... I advise my clients to limit their holdings of such speculative issues to around 25% of their portfolio. And, to widely diversify their stock base to protect themselves against those unpleasant surprises that spring up to bite every investor from time to time.

And, though I am bullish on young companies with superb management and rock-solid potential, I'll take any good growth stock where I can find it... including the NYSE... and even those "blue chip" issues that I foresee sprouting wings and flying once again... like Pfizer Pharmaceuticals.

Why do I like Pfizer? Aside from a long string of successful product introductions in the last two decades... a stunning run of recent FDA approvals... and the fact that Pfizer has been quietly forming strategic alliances with some of the hottest young biotech firms in America today... I will let you in on a little insider information which I doubt one single other investment analyst even has a clue about.

Imagine a pill that mimics the effect that glucose has on your nerve cells, fooling your brain into thinking it is full... and that completely kills your appetite for up to 18 hours. It has no known side effects other than imparting abundant energy... enhancing libido and sexual potency... and is reputed to have aphrodisiacal properties as well. Just how big do you think this could be?

Well... I am here to tell you that, for the past twenty years, Pfizer has been secretly working on just that-the miracle drug of this century! You see... some decades ago they purchased the proprietary knowledge of the use of the Hoodia cactus from South Africa's indigenous San-speaking Bushman tribes.

Now... word has leaked out from deep within the top-secret research labs of this pharmaceutical giant that Pfizer has finally succeeded in synthesizing the main chemical ingredient "P57" of this potent neutraceutical-a patentable breakthrough-and are looking forward to having it on the market in as soon as a year or two!

This is just one example of the kind of mind-opening information... that can make the astute investor's pulse race with excitement... you will find in every issue of The Rosenthal Report. Robert... With all the market "mood swings"... world instability... growing oil prices... etc., how can you be so sure your picks will be able to weather the tides?

There is nothing new about the spectacular rises and dizzying plunges the Stock Market has taken in recent times. Yet, over the market's entire history, many a good Growth Stock has weathered every storm, including the Great Depression, continuing to grow decade after decade, to make their stockholders incredibly rich. The secret lies in choosing solid companies, with a high growth potential, strong enough to survive economic downturns, bought at the right price.

Robert... Just what makes your investment newsletter different from all the rest... and the great value you say it is?

Although there are a few top-notch investment analysts out there... the bulk of the hundreds of investment newsletters I've seen are simply tag-a-longs that follow the trends-or guesswork.

For example... just this last spring, The NASDAQ Advisor ($195.00 a year) informed its readers that the NASDAQ was about to shoot up a thousand points, and that their picks were sure to rise 1,500% in a very short time. This misinformation just may have cost their readers a pretty penny!

The Rosenthal Report is different. My investment strategies... the depth of my research... and the simple fact that I have an uncanny knack for picking true winners... time after time... has made me one of the most sought after and highly paid personal investment advisors in America.

Furthermore, you will get the same tactics and picks I use to build my own portfolio. That's right. I put my money where my mouth is and invest my own precious dollars in the very same stocks I recommend to you in every issue of The Rosenthal Report. What does that tell you?

As for the cost... you will get what you pay for. Vital... valid... and superior information that can make the very difference between success and failure in the world of stock market investment.

Just this last June, a lucky few participants were privileged to fork over $2995.00 each to sit in on a three-day seminar on tech companies held at the Four Seasons Resort in Carlsbad, California. That is the kind of value astute investors put on the latest, breaking information.

Moreover, I am so completely confident that you will be amazed and pleased by the Superior Knowledge I give you in this powerful investment resource, that I will offer you something that I have never seen another investment newsletter publisher have the guts to offer.

I will give you a full 90 days to put the advice I give you in the The Rosenthal Report to the test. And, you won't have to risk a dime.

Simply, "pretend buy" the stocks I recommend... then keep track of their movement on paper for the next ninety days... and see how well they would have performed for you.

If you are not fully impressed by the potential The Rosenthal Report gives you to bring wonderful new money into your life... simply let me know... and I will promptly and courteously refund every penny of your subscription price.

That's how completely confident I am you will agree that the subscription price is "nothing" when compared to the wealth you too could be growing.

And... for a strictly limited time... in this exclusive offer only... I will make the deal even sweeter. Order right now and access the recommendations and the newsletter right this minute. Click Here To Order

This risk-free offer makes trying out this powerful information a true win-win situation!